APA (7th ed.) Citation

Wu, Q., Qian, W., Sun, X., & Jiang, S. (2022). Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021. Journal of hematology and oncology, 15(1), 143-63. https://doi.org/10.1186/s13045-022-01362-9

Chicago Style (17th ed.) Citation

Wu, Qing, Wei Qian, Xiaoli Sun, and Shaojie Jiang. "Small-molecule Inhibitors, Immune Checkpoint Inhibitors, and More: FDA-approved Novel Therapeutic Drugs for Solid Tumors from 1991 to 2021." Journal of Hematology and Oncology 15, no. 1 (2022): 143-63. https://doi.org/10.1186/s13045-022-01362-9.

MLA (9th ed.) Citation

Wu, Qing, et al. "Small-molecule Inhibitors, Immune Checkpoint Inhibitors, and More: FDA-approved Novel Therapeutic Drugs for Solid Tumors from 1991 to 2021." Journal of Hematology and Oncology, vol. 15, no. 1, 2022, pp. 143-63, https://doi.org/10.1186/s13045-022-01362-9.